Onderzoeker
Lore Vanderbeke
- Disciplines:Biochemie en metabolisme, Microbiologie, Systeembiologie, Laboratoriumgeneeskunde, Medische biochemie en metabolisme
Affiliaties
- Laboratorium voor Klinische Microbiologie (Afdeling)
Lid
Vanaf1 aug 2017 → Heden
Projecten
1 - 1 of 1
- De co-pathogenese van ernstige influenza infecties en invasieve pulmonale aspergillose.Vanaf1 okt 2017 → 30 sep 2022Financiering: FWO mandaten, BOF - Nieuwe Onderzoeksinitiatieven
Publicaties
1 - 10 van 24
- Lung epithelial and myeloid innate immunity in influenzaassociated or COVID-19-associated pulmonary aspergillosis: an observational study(2022)
Auteurs: Simon Feys, Bram Boeckx, Yves Debaveye, Greet Hermans, Stephanie Humblet-Baron, Katrien Lagrou, Laura Seldeslachts, Karin Thevissen, Christophe Vandenbriele, Lore Vanderbeke, et al.
Pagina's: 1147 - 1159 - Autoantibodies against type I IFNs in patients with critical influenza pneumonia(2022)
Auteurs: Isabelle Meyts, Joost Wauters, Lore Vanderbeke, Simon Feys
- Invasieve pulmonale aspergillose geassocieerd aan ernstige virale infecties op intensieve zorgen(2022)
Auteurs: Lore Vanderbeke, Greetje Vande Velde, Stephanie Humblet-Baron
- Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study(2022)
Auteurs: Ruth Van Daele, Joost Wauters, Erwin Dreesen, Lore Vanderbeke, Isabel Spriet
Pagina's: 656 - 660 - Longitudinal multimodal imaging-compatible mouse model of triazole sensitive and resistant invasive pulmonary aspergillosis(2022)
Auteurs: Agustin Reséndiz Sharpe, Lore Vanderbeke, Laura Seldeslachts, Katrien Lagrou, Greetje Vande Velde
- Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza(2022)
Auteurs: Seppe Cambier, Ana Carolina De Carvalho, Lore Vanderbeke, Bert Malengier-Devlies, Mieke Gouwy, Elisabeth Heylen, Greet Hermans, Els Wauters, Alexander Wilmer, Dominique Schols, et al.
- Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis1(2021)
Auteurs: Lore Vanderbeke, Katrien Lagrou, Simon Feys, Joost Wauters
Pagina's: 2892 - 2898 - Critical influenza and prophylactic antifungal therapy for aspergillosis: a nuanced approach to a pertinent infectious disease(2021)
Auteurs: Lore Vanderbeke, Katrien Lagrou, Joost Wauters
Pagina's: 1343 - 1344 - Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host(2021)
Auteurs: Veronica Llorens-Rico Llorens-Rico, Johan Van Weyenbergh, Sander Jansen, Junbin Qian, Soraya Menezes, Pierre Van Mol, Lore Vanderbeke, Christophe Dooms, Jan Gunst, Greet Hermans, et al.
- Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model(2021)
Auteurs: Laura Seldeslachts, Lore Vanderbeke, Agustin Reséndiz Sharpe, Tessa Ostyn, Lieve Naesens, Stephanie Humblet-Baron, Erik Verbeken, Katrien Lagrou, Joost Wauters, Greetje Vande Velde
Pagina's: 2493 - 2508